Collegium Pharmaceutical Inc (COLL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Collegium Pharmaceutical Inc-Aktie (COLL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.76% 188.00	177.76	159.30	145.28	144.92
Cost Of Revenue	1.02% 79.62	80.43	62.51	54.47	53.47
Gross Profit	11.36% 108.38	97.32	96.79	90.81	91.46
Operating Expenses	3.12% 73.28	75.64	61.95	43.34	41.98
Benefits Costs and Expenses	2.10% 170.97	174.63	143.72	116.18	108.30
Costs And Expenses	2.10% 170.97	174.63	143.72	116.18	108.30
Operating Income/Loss	61.87% 35.10	21.69	34.84	47.47	49.47
Income/Loss From Continuing Operations Before Tax	445.32% 17.02	3.122	15.58	29.10	36.62
Income Tax Expense/Benefit, Deferred	440.63% -2.914	-0.539	-8.733	-3.513	-4.412
Income Tax Expense/Benefit	615.18% 5.042	0.705	6.245	9.491	8.909
Income/Loss From Continuing Operations After Tax	395.78% 11.98	2.417	9.335	19.61	27.71
Net Income/Loss	395.78% 11.98	2.417	9.335	19.61	27.71
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.05% 31.81	31.79	32.26	32.43	32.33
Diluted Average Shares	18.99% 39.08	32.84	40.16	40.38	41.44
Basic Earnings Per Share	375.00% 0.38	0.08	0.29	0.60	0.86
Diluted Earnings Per Share	385.71% 0.34	0.07	0.27	0.52	0.71
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

HIMS

$44.39

2.35%

RDY

$13.41

0.90%

ELAN

$22.85

3.16%

VTRS

$10.53

1.64%

NBIX

$141.96

0.87%

UTHR

$438.66

1.52%